Works matching IS 20050380 AND DT 2022 AND VI 33
Results: 102
Overview of fuzuloparib in the treatment of ovarian cancer: background and future perspective.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e86
- By:
- Publication type:
- Article
ASGO 7th International Workshop on Gynecologic Oncology.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e85
- By:
- Publication type:
- Article
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e82
- By:
- Publication type:
- Article
LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e81
- By:
- Publication type:
- Article
Prognostic influence of an early time to chemotherapy following primary cytoreductive surgery for advanced epithelial ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e80
- By:
- Publication type:
- Article
Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as firstline treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e78
- By:
- Publication type:
- Article
Immunonutrition in ovarian cancer: clinical and immunological impact?
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e77
- By:
- Publication type:
- Article
The impact of interval between primary cytoreductive surgery with bowel resection and initiation of adjuvant chemotherapy on survival of women with advanced ovarian cancer: a multicenter cohort study.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e76
- By:
- Publication type:
- Article
SP1-induced lncRNA MCF2L-AS1 promotes cisplatin resistance in ovarian cancer by regulating IGF2BP1/IGF2/MEK/ERK axis.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e75
- By:
- Publication type:
- Article
Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e74
- By:
- Publication type:
- Article
Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial (KGOG2029/SELYE).
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e73
- By:
- Publication type:
- Article
Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 5, p. 1, doi. 10.3802/jgo.2022.33.e69
- By:
- Publication type:
- Article
Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e71
- By:
- Publication type:
- Article
Peritoneal dissemination of highgrade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 5, p. 1, doi. 10.3802/jgo.2022.33.e83
- By:
- Publication type:
- Article
Where is ERAS in the management of advanced ovarian cancer?: between myths and truths.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 5, p. 1, doi. 10.3802/jgo.2022.33.e79
- By:
- Publication type:
- Article
Cervical cancer patient reported gastrointestinal outcomes: intensity/ volumetric modulated vs. 3D conformal radiation therapy.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 5, p. 1, doi. 10.3802/jgo.2022.33.e70
- By:
- Publication type:
- Article
Epidemiologic study on gestational trophoblastic diseases in Japan.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e72
- By:
- Publication type:
- Article
Frequency and clinical features of deficient mismatch repair in ovarian clear cell and endometrioid carcinoma.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 5, p. 1, doi. 10.3802/jgo.2022.33.e67
- By:
- Publication type:
- Article
The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 5, p. 1, doi. 10.3802/jgo.2022.33.e66
- By:
- Publication type:
- Article
Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 5, p. 1, doi. 10.3802/jgo.2022.33.e62
- By:
- Publication type:
- Article
Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO).
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 5, p. 1, doi. 10.3802/jgo.2022.33.e61
- By:
- Publication type:
- Article
Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 5, p. 1, doi. 10.3802/jgo.2022.33.e60
- By:
- Publication type:
- Article
Prognostic factors of dose-response relationship for nodal control in metastatic lymph nodes of cervical cancer patients undergoing definitive radiotherapy with concurrent chemotherapy.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 5, p. 1, doi. 10.3802/jgo.2022.33.e59
- By:
- Publication type:
- Article
Incidence and risk factors for the development of cerebral metastasis in cervical cancer patients.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 5, p. 1, doi. 10.3802/jgo.2022.33.e58
- By:
- Publication type:
- Article
Development of a prognostic prediction support system for cervical intraepithelial neoplasia using artificial intelligence-based diagnosis.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 5, p. 1, doi. 10.3802/jgo.2022.33.e57
- By:
- Publication type:
- Article
Rotational intraperitoneal pressurized aerosol chemotherapy with paclitaxel and cisplatin: pharmacokinetics, tissue concentrations, and toxicities in a pig model.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 5, p. 1, doi. 10.3802/jgo.2022.33.e56
- By:
- Publication type:
- Article
A carrier as a gynecologic oncologist in an academic hospital in a developing country.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S15, doi. 10.3802/jgo.2022.33.S15
- By:
- Publication type:
- Article
Diagnostic performance of magnetic resonance imaging (MRI) in patients with operable cervical cancer: a retrospective analysis.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S14, doi. 10.3802/jgo.2022.33.S14
- By:
- Publication type:
- Article
The randomized controlled trial on the efficacy of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICr.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S13, doi. 10.3802/jgo.2022.33.S13
- By:
- Publication type:
- Article
Exploiting DNA replication stress for sequential therapy with PARP and WEE1 inhibitors.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S12, doi. 10.3802/jgo.2022.33.S12
- By:
- Publication type:
- Article
Real-world outcomes of niraparib treatment in patients with ovarian cancer: the first observational multicenter study in China.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S11, doi. 10.3802/jgo.2022.33.S11
- By:
- Publication type:
- Article
Significance of TCGA molecular classification in fertility-sparing treatment of endometrial cancer and atypical hyperplasia.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S10, doi. 10.3802/jgo.2022.33.S10
- By:
- Publication type:
- Article
Epithelial-mesenchymal transition in fertility sparing management of endometrial cancer: report of two cases.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S9, doi. 10.3802/jgo.2022.33.S9
- By:
- Publication type:
- Article
A case of isolated inguinal nodal cancer of Mullerian origin.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S8, doi. 10.3802/jgo.2022.33.S8
- By:
- Publication type:
- Article
A prospective multicenter cohort study comparing vNOTES and laparoscopic sentinel lymph node mapping for endometrial cancer.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S7, doi. 10.3802/jgo.2022.33.S7
- By:
- Publication type:
- Article
Efficacy of PARPi monotherapy and the impact to subsequent platinum-based chemotherapy in BRCA1/2 mutant ovarian cancer patients with secondary platinum-sensitive relapse.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S6, doi. 10.3802/jgo.2022.33.S6
- By:
- Publication type:
- Article
Oncological and reproductive outcomes after fertility-sparing surgery in patients with seromucinous borderline ovarian tumor: results of a large retrospective study.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S5, doi. 10.3802/jgo.2022.33.S5
- By:
- Publication type:
- Article
Single-cell transcriptomics reveals tumor landscape in ovarian carcinosarcoma.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S4, doi. 10.3802/jgo.2022.33.S4
- By:
- Publication type:
- Article
The acceptability of vaginal self-sampling for human papillomavirus (HPV) testing among a multi-ethnic Asian female population.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S3, doi. 10.3802/jgo.2022.33.S3
- By:
- Publication type:
- Article
Psychosocial burden in women with positive human papillomavirus testing after abnormal cervical cytology: atypical squamous cells of undetermined significance (ASC-US).
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S2, doi. 10.3802/jgo.2022.33.S2
- By:
- Publication type:
- Article
Novel therapeutic approach for uterine leiomyosarcoma based on transcriptome analysis.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, p. S1, doi. 10.3802/jgo.2022.33.S1
- By:
- Publication type:
- Article
Turning up the heat does not affect quality of life.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 4, p. 1, doi. 10.3802/jgo.2022.33.e68
- By:
- Publication type:
- Article
Book Review: IARC handbooks of cancer prevention, volume 18: Cervical cancer screening.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 4, p. 1, doi. 10.3802/jgo.2022.33.e65
- By:
- Publication type:
- Article
A step towards the ambition of precision oncology in recurrent ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 4, p. 1, doi. 10.3802/jgo.2022.33.e64
- By:
- Publication type:
- Article
Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 4, p. 1, doi. 10.3802/jgo.2022.33.e63
- Publication type:
- Article
Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052).
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 4, p. 1, doi. 10.3802/jgo.2022.33.e55
- By:
- Publication type:
- Article
Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01).
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 4, p. 1, doi. 10.3802/jgo.2022.33.e54
- By:
- Publication type:
- Article
Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 4, p. 1, doi. 10.3802/jgo.2022.33.e53
- By:
- Publication type:
- Article
Bone health after RRBSO among BRCA1/2 mutation carriers: a population-based study.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 4, p. 1, doi. 10.3802/jgo.2022.33.e51
- By:
- Publication type:
- Article
TP53 variants in p53 signatures and the clonality of STICs in RRSO samples.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 4, p. 1, doi. 10.3802/jgo.2022.33.e50
- By:
- Publication type:
- Article